Clinical Trials Browser

Phase 1/2 × Transplantation, Autologous × Plasma cell × Clear all

NCT00024466 2018-09-19

Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

Phase 1/2 Completed

Multiple Myeloma

NCT02353572 2015-03-09

Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

Phase 1/2 Terminated

3 enrolled 5 charts

Smoldering Multiple Myeloma, Multiple Myeloma